Assyro AI

Orange Book product · Brand (NDA)

JANUVIA

SITAGLIPTIN PHOSPHATE

Brand (NDA)NDA 021995TE ABRX MSD

At a glance

Oct 16, 2006

Approved

Brand (NDA)

Application

AB

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 16, 2006

    20 yr ago

  2. Today

  3. Patent 7326708 expires

    Listed drug substance patent expiration.

    Nov 24, 2026

    in 5 mo

  4. Patent 7326708*PED expires

    Listed listed patent expiration.

    May 24, 2027

    in 11 mo

Pharmaceutical detail

Active ingredient

SITAGLIPTIN PHOSPHATE

Strength

EQ 25MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

NDA 021995

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7326708Nov 24, 2026in 5 mo
SubstanceProductU-802
7326708*PEDMay 24, 2027in 11 mo
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.